[Federal Register: June 1, 2004 (Volume 69, Number 105)]
[Notices]
[Page 30917-30918]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr01jn04-88]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-54-04]
Proposed Data Collections Submitted for Public Comment and
Recommendations
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 498-1210 or send an e-mail
to omb@cdc.gov. Send written comments to CDC, Desk Officer, Human
Resources and Housing Branch, New Executive Office Building, Room
10235, Washington, DC 20503 or by fax to (202) 395-6974. Written
comments should be received within 30 days of this notice.
Proposed Project
Evaluation of Educational Materials Promoting Informed Decision-
Making About Prostate Cancer Screening--New--National Center for
Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Prostate cancer is the second most commonly diagnosed cancer among
men in the United States. In 2003, an estimated 220,900 new cases of
prostate cancer was diagnosed, and approximately 28,900 men died from
the disease. The effectiveness of prostate cancer screening has not
been established. A number of clinical guidelines recommend that the
potential
[[Page 30918]]
risks and benefits of prostate cancer screening be explained to
patients so that they may make an informed decision about screening.
The purpose of this project is to evaluate the effectiveness of an
informed-decision making booklet about prostate cancer screening
developed by CDC.
This is a 3-year project that will be conducted in two phases of
which 3 major tasks must be completed. In Task-1, the reliability and
validity of a measurement instrument assessing prostate cancer
knowledge and related variables will be tested. Two hundred men of all
races aged 50 to 70 years and 200 African-American men aged 40 to 70
years will read the CDC booklet and complete the measurement
instrument. In Task-2, 150 primary care physicians will complete a
survey measuring their prostate cancer screening practices. The survey
will be administered once and then again several months later. In Task-
3, 400 men aged 50-70 years will take part in a randomized controlled
trial. Men in the intervention group will be asked to read the CDC
booklet and complete the measurement instrument tested in Task-1, and
men in the control group will complete the measurement instrument
without reading the CDC booklet. There is no cost to respondent except
for their time.
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Phase I: Replicate Measures Validation Study
----------------------------------------------------------------------------------------------------------------
Eligibility Screener............................ 147 1 15/60 37
Pre-visit Instrument 1.......................... 133 1 \1\15/60 33
Pre-visit Instrument 2.......................... 133 1 \2\ 30/60 67
After visit Instrument.......................... 133 1 20/60 44
-------------------------------------------------
Phase II: Randomized Controlled Trial
----------------------------------------------------------------------------------------------------------------
Eligibility Screener............................ 160 1 15/60 40
Pre-visit Instrument 1.......................... 133 1 15/60 33
Pre-visit Instrument 2.......................... 67 1 30/60 34
After visit Instrument.......................... 133 1 30/60 67
Provider Practice Screener 1 (Pre-RCT).......... 50 1 15/60 13
Provider Practice Screener 2 (Pre-RCT).......... 50 1 15/60 13
-----------------
Total....................................... .............. .............. .............. 381
----------------------------------------------------------------------------------------------------------------
\1\ Includes preparation and returning the survey via mail service.
\2\ Includes an estimate of 25 minutes for reviewing the decision aid material.
Dated: May 20, 2004.
Joe E. Salter,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 04-12225 Filed 5-28-04; 8:45 am]
BILLING CODE 4163-18-P